Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide +/- Prednisone in Myelofibrosis
NCT00463385Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Apr 2007
- Primary completion
- May 2009
- Modality
- Molecular Glues
- Countries
- 5
01
Overview
A Phase 2 trial of pomalidomide in myelofibrosis (MF), sponsored by Celgene Corporation. Started Apr 2007; status: completed.
02
Drugs
pomalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00463385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463385.